DMD models exhibit dysregulation of inflammatory signaling pathways, including nuclear factor kappa B (NF-κB) or its downstream mediators, including tumor necrosis factor alpha (TNFα), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β) [60]. The gene discussed is IL1B; the disease is Duchenne muscular dystrophy.